Stay informed with the latest litigation news. Explore now

IP Verse

A Dosing Regime And Formulations For Type B Adenoviruses - EP3007711B1

EP3007711

AKAMIS BIO
Application Number
EP14736650A
Filing Date
Jun 12, 2014
Status
Granted And Under Opposition
Sep 18, 2020
Grant Date
Oct 21, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3007711B1 was granted to Akamis BIO on Oct 21, 2020 following the initial filing on Jun 12, 2014 under the application number EP14736650A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHNSJul 19, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents